Prospective Evaluation of NfL as a Biomarker in ATTRv
Prospective Evaluation of NfL as a Biomarker in ATTRv
Active, not recruiting · NCT05879874 · Registry updated 2025-08-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prospective Evaluation of NfL as a Biomarker in ATTRv | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Disease Progression, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, amyloidosis, hereditary amyloidosis, hereditary disease, inborn errors of metabolism, metabolic disease, proteostasis deficiencies | Active, not recruiting | Not stated | 2025-08-14 | NCT05879874 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 491 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fondazione Policlinico Gemelli IRCCS | Rome | Italy | 2 |